Iron Replacement Therapy for Secondary Thrombocytosis in Inflammatory Bowel Disease: Results of a Randomized Controlled Study – The ThromboVIT Trial
✍ Scribed by Kulnigg-Dabsch, Stefanie ;Schmid, Werner ;Howaldt, Stefanie M. ;Stein, Jürgen ;Evstatiev, Rayko ;Waldhoer, Thomas ;Volf, Ivo ;Gasche, Christoph
- Book ID
- 122330349
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 240 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: The use of stress management psychotherapy is hypothesized to produce greater improvement in disease course and disease-specific quality of life (IBDQ) compared to usual medical care alone in patients with ulcerative colitis (UC) or Crohn's disease (CD) showing high levels of stress (bas
## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to